Literature DB >> 33517831

Decline of serologic immunity to diphtheria, tetanus and pertussis with age suggested a full life vaccination in mainland China.

Dandan Liu1, Xiaoping Cheng2, Shi Wei1, Lin Yuan, Changhui Chen3, Kaihu Yao1.   

Abstract

Background: Diphtheria-tetanus-pertussis (DTP) vaccine has already been involved in national vaccination program for several decades in China. The immunity against these diseases in the people of all ages is not well investigated.Materials and methods: Serum samples were tested for IgG antibodies to diphtheria toxoid (DT), tetanus toxoid (TT) and pertussis toxin (PT) by using commercial ELISA kits.
Results: A total of 666 sera of patients from 1 day to 89 years of age was collected from 2018 to 2019. The protective rates of diphtheria, tetanus and pertussis were 45.5%, 54.4% and 4.7%, respectively. Only 4.7% of the study population had seropositivity against three of the diseases. Young infant (<3 m) and adult (>18y) were generally lack of protective antibody against diphtheria (81.7% and 58.3%) and tetanus (91.5% and 86.2%). An obvious increase in immunity level of diphtheria and tetanus was observed at 3 m-3y, but there was no significant increase of immunity to pertussis at any age group. All age groups showed low immunity to pertussis.Conclusions: The present results revealed the susceptibility to diphtheria and tetanus in young infants and adults, and the susceptibility to pertussis over the ages, which highlight the need to improve the current vaccination program.

Entities:  

Keywords:  Pertussis; diphtheria; seroprevalence; tetanus; vaccination

Mesh:

Substances:

Year:  2021        PMID: 33517831      PMCID: PMC8115445          DOI: 10.1080/21645515.2020.1840253

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  24 in total

Review 1.  Adverse reactions to vaccines practice parameter 2012 update.

Authors:  John M Kelso; Matthew J Greenhawt; James T Li; Richard A Nicklas; David I Bernstein; Joann Blessing-Moore; Linda Cox; David Khan; David M Lang; John Oppenheimer; Jay M Portnoy; Christopher R Randolph; Diane E Schuller; Sheldon L Spector; Stephen A Tilles; Dana Wallace
Journal:  J Allergy Clin Immunol       Date:  2012-05-16       Impact factor: 10.793

2.  Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.

Authors:  H Theeten; V Hutse; N Hens; Y Yavuz; K Hoppenbrouwers; P Beutels; R Vranckx; P Van Damme
Journal:  Epidemiol Infect       Date:  2010-06-29       Impact factor: 2.451

3.  Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins.

Authors:  Lotte H Hendrikx; Kemal Oztürk; Lia G H de Rond; Reinier H Veenhoven; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Vaccine       Date:  2010-12-25       Impact factor: 3.641

4.  Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study.

Authors:  Xiaomei Li; Meng Chen; Tiegang Zhang; Juan Li; Yang Zeng; Li Lu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  China's vaccine production scare.

Authors:  Xun Yuan
Journal:  Lancet       Date:  2018-08-02       Impact factor: 79.321

6.  Seroprevalence of pertussis in China: need to improve vaccination strategies.

Authors:  Yinghua Xu; Lichan Wang; Jin Xu; Xinjian Wang; Chen Wei; Peng Luo; Xiao Ma; Qiming Hou; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-09-09       Impact factor: 3.452

7.  Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.

Authors:  Flor M Munoz; Nanette H Bond; Maurizio Maccato; Phillip Pinell; Hunter A Hammill; Geeta K Swamy; Emmanuel B Walter; Lisa A Jackson; Janet A Englund; Morven S Edwards; C Mary Healy; Carey R Petrie; Jennifer Ferreira; Johannes B Goll; Carol J Baker
Journal:  JAMA       Date:  2014-05-07       Impact factor: 56.272

Review 8.  Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential.

Authors:  Erich V Scheller; Peggy A Cotter
Journal:  Pathog Dis       Date:  2015-09-27       Impact factor: 3.166

9.  Global Routine Vaccination Coverage, 2018.

Authors:  Megan Peck; Marta Gacic-Dobo; Mamadou S Diallo; Yoann Nedelec; Samir S Sodha; Aaron S Wallace
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-10-25       Impact factor: 17.586

Review 10.  Roads to the development of improved pertussis vaccines paved by immunology.

Authors:  Jolanda Brummelman; Mieszko M Wilk; Wanda G H Han; Cécile A C M van Els; Kingston H G Mills
Journal:  Pathog Dis       Date:  2015-09-06       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.